Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001871002-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-16 | 2024-02-14 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $0.00 | +22.4K | 51.3K | +77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | A | A | 13,421 | $0.00 | 42,368 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | A | A | 8,946 | $0.00 | 51,314 | D | — | — |